Pluripotent Stem Cells for Spinal Cord Injury Repair

Spinal cord injury (SCI) is a serious condition that lowers a patient's quality of life and places a significant financial burden on the healthcare system. Cell therapy is a promising avenue for SCI treatment. Stem cells are particularly attractive because of their ability to self-renew and differentiate into various cell types, making them suitable for developing new cell therapies. Pluripotent stem cells (PSCs), including embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), are a promising cell source. These cells can differentiate into any cell type in the body, but using them in SCI treatment faces challenges. Researchers are exploring ways to use PSC-derived cells to repair SCI, focusing on key observations and drawing conclusions from existing studies. Scientists are trying to use cells derived from pluripotent stem cells to treat spinal cord injuries. However, simply injecting undifferentiated stem cells can lead to tumor formation, which is dangerous. Therefore, research focuses on using cells that have been guided to develop into specific types of neural cells before being transplanted.

• 1
  ESC-derived cells have shown efficacy in acute SCI models in animals, suggesting potential for human therapies, but require further optimization and safety measures to address tumorigenic risks.
• 2
  iPSC-derived cells have demonstrated efficacy in animal models, particularly in acute thoracic SCI, but concerns remain regarding genetic abnormalities, immune responses, and tumorigenicity that need to be carefully addressed for clinical applications.
• 3
  Combining cell therapies with tissue scaffolds, growth factors, and anti-inflammatory agents may improve outcomes for both acute and chronic SCI by addressing cavitation, promoting axonal growth, and enhancing cell survival.